Phio Pharmaceuticals Corp.

8-K Director or officer change; Other events Jul 21, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Entered a material agreement Apr 8, 2026 8-K Other events Mar 30, 2026 10-K Fiscal year ended 2025-12-31 Mar 5, 2026 8-K Results of operations (earnings release) Mar 5, 2026 8-K Director or officer change Feb 18, 2026 8-K Other events Feb 10, 2026 8-K Other events Jan 20, 2026 8-K Other events Dec 23, 2025 8-K Other events Nov 25, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Results of operations (earnings release) Nov 13, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Nov 6, 2025 8-K Other events Nov 3, 2025 8-K Director or officer change; Other events Oct 31, 2025 8-K Director or officer change; Shareholder vote results Sep 15, 2025 8-K Other events Sep 3, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release) Aug 14, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Jul 30, 2025 8-K Other events Jul 25, 2025 8-K Other events Jul 7, 2025 8-K Other events Jun 26, 2025 8-K Director or officer change Jun 12, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Results of operations (earnings release) May 15, 2025 8-K Other events May 7, 2025 8-K Changed accountants Apr 22, 2025 8-K Other events Apr 9, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Results of operations (earnings release) Mar 31, 2025 8-K Director or officer change; Other events Feb 20, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Jan 17, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Jan 15, 2025 8-K Entered a material agreement; Other events Jan 14, 2025 8-K Other events Jan 13, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Dec 26, 2024 8-K Entered a material agreement; Unregistered sale of equity; Other events Dec 20, 2024